View Author
scopus: 24587826200

Koopman, M.

(Miriam Koopman)


patient cancer colorectal treatment colorectal cancer metastatic colorectal cancer study oxaliplatin resection 5- fu /lv irinotecan survival metastatic trial chemotherapy regimen fluorouracil oncol capecitabine therapy stage folfox perspective colon cost-effectiveness erasmus mc resection resection hospital result raltitrexed bevacizumab leucovorin article tumour adjuvant netherland review adjuvant chemotherapy expert analysis pharmacother 5 fu /lv metastase erasmu schedule guideline first-line outcome surgery health disease phase mosaic trial practice month mosaic infusion combination quality 48 h infusion downloaded group cetuximab effect expert opin analyses cost-effectiveness ratio capox unresectable life year adjuvant treatment gramont liver fluoropyrimidine folfiri first-line treatment table 08/08/12 ef ficacy administration




4 Most Recent Publications

Comparison of treatment outcome in metastatic colorectal cancer patients included in a clinical trial versus daily practice in the Netherlands (Article)
Mol, L. Koopman, M. Gils, C.W.M. van Ottevanger, P.B. Punt, C.J.A.
2013-06-01
Adjuvant chemotherapy in stage III colon cancer: Guideline implementation, patterns of use and outcomes in daily practice in the Netherlands (Article)
Gils, C.W.M. van Koopman, M. Mol, L. Orlewska, E. Uyl-de Groot, C.A. Punt, C.J.A.
2012-01-01
Surgery of the primary in stage IV colorectal cancer with unresectable metastases (Article)
Verhoe, C. Wilt, J.H.W. de Burger, J.W.A. Verheu, H.M.W. Koopman, M.
2011-09-01
A systematic review of economic analyses of pharmaceutical therapies for advanced colorectal cancer (Article)
Krol, H.M. Koopman, M. Uyl-de Groot, C.A. Punt, C.J.A.
2007-06-01